- Report
- October 2025
- 198 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 392 Pages
Global
From €5164EUR$5,850USD£4,505GBP
- Report
- August 2025
- 189 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- January 2025
- 163 Pages
Global
From €2112EUR$2,392USD£1,842GBP
€2639EUR$2,990USD£2,302GBP
- Report
- August 2025
- 180 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- August 2025
- 182 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- August 2025
- 196 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- August 2025
- 189 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- August 2025
- 194 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- August 2025
- 185 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 194 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 180 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 198 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 187 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 189 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 184 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 185 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 195 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- October 2025
- 181 Pages
Global
From €3129EUR$3,545USD£2,730GBP
€3477EUR$3,939USD£3,033GBP
- Report
- September 2025
- 250 Pages
Global
From €3964EUR$4,490USD£3,457GBP

The Antibody Production market is a segment of the biopharmaceutical industry that focuses on the production of antibodies for therapeutic and diagnostic purposes. Antibodies are proteins that are produced by the immune system to recognize and bind to specific antigens, such as bacteria and viruses. Antibody production involves the use of recombinant DNA technology to produce large quantities of antibodies for use in research, diagnostics, and therapeutics. The market is driven by the increasing demand for biopharmaceuticals, as well as the development of new technologies and techniques for producing antibodies.
The Antibody Production market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more